<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00603681</url>
  </required_header>
  <id_info>
    <org_study_id>3066001</org_study_id>
    <nct_id>NCT00603681</nct_id>
  </id_info>
  <brief_title>Comparison of PEG Solutions With and Without Electrolytes in the Treatment of Constipation</brief_title>
  <acronym>PEGorion</acronym>
  <official_title>Non-Inferiority Study; Comparison of Polyethylene Glycol Solution With and Without Electrolytes for Treatment of Chronic Constipation in Elderly Institutionalised Patients: a Double-Blind, Randomised, Parallel-Group, Multicentre Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Orion Corporation, Orion Pharma</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Orion Corporation, Orion Pharma</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to show that new polyethylene glycol (PEG) solution without
      electrolytes is as effective in the treatment of constipation as PEG solution with
      electrolytes in the elderly institutionalized people. Also, the tolerability and the safety
      of the study drug will be examined.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Constipation is a major problem in elderly institutionalised patients. Non-pharmacological
      treatments are proposed as primary management of constipation, but institutionalised patients
      are not likely to be able to increase either the intake of dietary fibre or fluid and their
      physical activity is low.

      The latest agent widely used for the treatment of constipation is polyethylene glycol (PEG).
      PEG is classified into the group of osmotic laxatives. It is minimally absorbed from the
      gastrointestinal tract and not metabolised by colonic bacteria.

      Most of the PEG products at the market contain electrolytes and have a salty and unpleasant
      taste which may affect the compliance of using them. A PEG solution without electrolytes has
      been developed and used for some years in various countries. Now we will compare the efficacy
      and safety of PEG solutions with or without electrolytes and their acceptability in the use
      for constipation in institutionalised patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">July 2008</completion_date>
  <primary_completion_date type="Actual">July 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Stool frequency</measure>
    <time_frame>week 4</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stool frequency</measure>
    <time_frame>Week 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool straining</measure>
    <time_frame>Weeks 2 and 4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stool consistency</measure>
    <time_frame>Weeks 2 and 4</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>Constipation</condition>
  <arm_group>
    <arm_group_label>T</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test product</description>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Reference product</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Polyethylene glycol 4000</intervention_name>
    <description>powder for oral solution 12 g of PEG once a day, twice a day or once every other day for 4 weeks</description>
    <arm_group_label>T</arm_group_label>
    <other_name>Pegorion</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Polyethylene glycol 4000 with electrolytes</intervention_name>
    <description>granules for oral solution 12 g of PEG once a day, twice a day or once every other day for 4 weeks</description>
    <arm_group_label>C</arm_group_label>
    <other_name>Colonsoft</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Isotonic PEG treatment for constipation at the stable dose for at least 2 weeks before
             the run-in period

        Exclusion Criteria:

          -  Other medical treatment for constipation than isotonic PEG or plantago ovata seeds

          -  Severe dementia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lauri Seinelä, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pirkanmaan erikoislääkäripalvelu Oy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ulla Sairanen, MSc</last_name>
    <role>Study Director</role>
    <affiliation>Orion Corporation, Orion Pharma</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Koskikoti</name>
      <address>
        <city>Tampere</city>
        <zip>33100</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Koivupirtti</name>
      <address>
        <city>Tampere</city>
        <zip>33500</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tampereen sotainvalidien Veljeskoti</name>
      <address>
        <city>Tampere</city>
        <zip>33500</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lahdensivun koti</name>
      <address>
        <city>Tampere</city>
        <zip>33560</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nurmikoti</name>
      <address>
        <city>Tampere</city>
        <zip>33680</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Vire Koti Kaukaharju assisted-living facility</name>
      <address>
        <city>Tampere</city>
        <zip>33710</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Taatala assested-living facility</name>
      <address>
        <city>Tampere</city>
        <zip>33820</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kuusela assisted-living facility</name>
      <address>
        <city>Tampere</city>
        <zip>33900</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Petäjäkoti</name>
      <address>
        <city>Tampere</city>
        <zip>33900</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nursing home of Tiuravuori</name>
      <address>
        <city>Ylöjärvi</city>
        <zip>33480</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2008</study_first_submitted>
  <study_first_submitted_qc>January 28, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 29, 2008</study_first_posted>
  <last_update_submitted>October 6, 2008</last_update_submitted>
  <last_update_submitted_qc>October 6, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2008</last_update_posted>
  <responsible_party>
    <name_title>Ulla Sairanen</name_title>
    <organization>Orion Pharma</organization>
  </responsible_party>
  <keyword>constipation</keyword>
  <keyword>aged</keyword>
  <keyword>polyethylene glycol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

